GlaxoSmithKline Regrets Shameful Behavior in China Bribe Scandal

More accusations have surfaced concerning GlaxoSmithKline’s actions in China, including several counts of bribery of doctors and requests for certain “favors” in exchange for expanded Chinese market share; four company officials are still in detention in the country. GSK claims it is deeply concerned and apologetic for its employees’ transgressions.
Pharma Times